Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Isis Pharma Closes Preapproval Inspection Of Manufacturingfacility In California

8/3/2012 3:51 PM ET

Isis Pharmaceuticals, Inc. (ISIS: Quote) announced that it has successfully completed a pre-approval inspection of its manufacturing facility located in Carlsbad, California.

As part of the inspection, the European Medicines Agency (EMA) conducted an extensive review of Isis' manufacturing facility and processes and Isis' Good Manufacturing Practices (GMP) Quality systems to ensure product manufactured is of appropriate and reliable quality.

The EMA's approval of the Isis manufacturing facility allows Isis to supply Genzyme with Kynamro drug substance to support commercial launch in Europe.

Click here to receive FREE breaking news email alerts for ISIS Pharmaceuticals Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving sharply lower at the open, stocks have regained some ground over the course of morning trading on Thursday. The major averages have climbed well off their worst levels of the day but remain stuck in the red. In another upbeat sign for the U.S. housing market, the Commerce Department released a report on Thursday showing that new home sales came in well above economist estimates in the month of April. The report showed that new home sales climbed 2.3 percent to a seasonally adjusted annual rate of 454,000 in April from the revised March rate of 444,000. Consumer sentiment in the euro area increased for the sixth consecutive month in May to its strongest level since the middle of last year, preliminary data from the European Commission showed Thursday. The DG ECFIN flash estimate of the consumer confidence indicator for Eurozone came in at -21.9,...
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.